SCHEMBL999994

SCHEMBL999994

CC(CCCCN=C=O)CCCCN=C=O

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
ACE2 Q9BYF1 1/20 0.32
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4457453 0.98 LMNA (0.39) LMNAACE2
SCHEMBL5841490 0.96 LMNA (0.37) LMNAACE2
SCHEMBL10316530 0.94 LMNA (0.36) LMNAACE2
SCHEMBL11660910 0.93 LMNA (0.36) LMNABLM
SCHEMBL28149697 0.92 ACE2 (0.40) LMNAACE2
SCHEMBL28403399 0.91 LMNA (0.40) LMNAACE2BLM
SCHEMBL11615998 0.90 ACE2 (0.47) ACE2
SCHEMBL10456184 0.89 LMNA (0.31) LMNA
SCHEMBL7703603 0.89 LMNA (0.31) LMNA
SCHEMBL868602 0.88 LMNA (0.33) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026055875-A9 ONE-COMPONENT (1K) HEAT-ACTIVATABLE WATERBORNE POLYURETHANE ADHESIVE AND USE THEREOF HENKEL AG & CO. KGAA (DE) 2026-05-15 WO claimed
WO-2026040069-A1 REACTIVE HOT-MELT ADHESIVE COMPOSITION AND USE THEREOF HENKEL AG & CO. KGAA (DE) 2026-02-26 WO claimed
EP-4380990-A1 DUAL-CURE RESIN COMPOSITION COMPRISING URETDIONE-CONTAINING COMPOUND AND ITS USE IN 3D PRINTING BASF SE (DE) 2024-06-12 EP claimed
US-20240141093-A1 Polyol and a Process for the Preparation Thereof BASF SE (DE) 2024-05-02 US claimed
CN-117836344-A Dual cure resin composition comprising uretdione containing compounds and use thereof in 3D printing 巴斯夫欧洲公司 2024-04-05 CN claimed
WO-2024033289-A1 A PHOTOCURABLE OLIGOMER CONTAINING URETDIONE GROUPS, METHOD OF PREPARING THE OLIGOMER AND DUAL-CURE RESIN COMPOSITION CONTAINING THE OLIGOMER THEREOF BASF SE (DE) 2024-02-15 WO claimed
EP-4308629-A1 POLYOL AND A PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2024-01-24 EP claimed
EP-4305085-A1 POLYUREA COPOLYMER BASF SE (DE) 2024-01-17 EP claimed
CN-116997590-A Polyol and process for producing the same 巴斯夫欧洲公司 2023-11-03 CN claimed
CN-116964122-A Polyurea copolymers 巴斯夫欧洲公司 2023-10-27 CN claimed
US-20130220507-A1 BALLISTIC RESILIENT RUN-FLAT TIRE, KIT AND METHOD THEREOF ARNCO (US) 2013-08-29 US claimed
EP-2367864-B1 LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS EVONIK DEGUSSA GMBH (DE) 2012-10-03 EP claimed
US-20110251424-A1 LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS EVONIK DEGUSSA GMBH (DE) 2011-10-13 US claimed
EP-1136495-B1 1:1 monoadducts of aminoalkylalkoxysilanes and diisocyanates, their preparation and use DEGUSSA (DE) 2006-06-28 EP claimed
EP-0798322-A1 Blocked (cyclo)aliphatic diisocyanates containing carbodiimide groups, a process for their preparation as well as their use HÜLS AKTIENGESELLSCHAFT (DE) 1997-10-01 EP claimed
EP-0789044-A1 Blocked and chain-extended diisocyanate adducts, a process for their preparation as well as their use HÜLS AKTIENGESELLSCHAFT (DE) 1997-08-13 EP claimed
EP-0787754-A2 Blocked aliphatic diisocyanates or diisocyanate-adducts HÜLS AKTIENGESELLSCHAFT (DE) 1997-08-06 EP claimed
US-5149805-A Blocked with caprolactam, methyl ethyl ketoxime or diisobutyl ketoxime HUELS AKTIENGESELLSCHAFT (DE) 1992-09-22 US claimed
US-4243793-A Prepolymers for photocurable compositions PHILLIPS PETROLEUM COMPANY (US) 1981-01-06 US claimed
US-4119510-A Photocurable diisocyanate compositions PHILLIPS PETROLEUM COMPANY (US) 1978-10-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251424-A1 LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS CYP1B1, HCFC1, DIMT1 LMNA 4168/4885ACE2 939/4885BLM 1368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.